| Literature DB >> 32722703 |
René Schilling1, Flora Colledge1, Uwe Pühse1, Markus Gerber1.
Abstract
Metabolic syndrome (MetS) is a worldwide health concern related to cardiovascular disease. Stress at work increases the risk for MetS, whereas physical activity and cardiorespiratory fitness (CF) have been shown to be potential buffers against stress. The aim of this study was to test the stress-buffering effects of physical activity and CF on the relationship between work stress and MetS. In a prospective study, we followed 97 police officers (mean age = 39.7 years; mean body mass index = 25.74 kg/m2) over one year and assessed MetS, as defined by the National Cholesterol Education Program Adult Treatment Panel III. Stress at work was measured with the Job Content Questionnaire, as well as the Effort-Reward Imbalance Questionnaire. Physical activity was assessed objectively via 7-day accelerometry. CF was assessed with the Åstrand bicycle ergometer test. Hierarchical linear regression models were carried out to predict MetS at follow-up (mean overall MetS score = 1.22), after controlling for baseline levels and sociodemographic background (mean overall MetS score = 1.19). Higher CF levels were significantly associated with lower MetS risk at follow-up (β = -.38). By contrast, no main effects were found for physical activity and work stress. However, high effort and demand were significantly correlated with increased blood pressure (effort: r = .23 for systolic blood pressure; r = .21 for diastolic blood pressure) and waist circumference (effort: r = .26; demand: r = .23). Moreover, no significant interaction effects occurred between work stress and CF/physical activity. The results emphasize the importance of high levels of CF in the prevention of MetS in police officers. Accordingly, provision of regular training opportunities and repeated CF testing should be considered as a strategy in overall corporate health promotion.Entities:
Mesh:
Year: 2020 PMID: 32722703 PMCID: PMC7386627 DOI: 10.1371/journal.pone.0236526
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Differences between participants who were lost to follow-up and participants who completed both data assessments in sociodemographic background and predictor and outcome variables.
| Baseline | All participants | Participants lost to follow-up | Participants who completed the follow-up | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Socio-demographics | ||||||||||||
| Age (years) | 201 | 38.55 | 10.13 | 104 | 37.45 | 10.55 | 97 | 39.73 | 9.59 | -1.60 | .11 | -0.23 |
| Relationship status (single = 1, relationship = 2) | 189 | 1.80 | 0.40 | 97 | 1.81 | 0.39 | 92 | 1.78 | 0.41 | 0.54 | .59 | 0.08 |
| Education (1–7) | 188 | 3.15 | 1.51 | 95 | 3.14 | 1.55 | 93 | 3.17 | 1.48 | -0.16 | .87 | -0.02 |
| Children (yes = 1; no = 2) | 190 | 1.57 | 0.50 | 97 | 1.59 | 0.49 | 93 | 1.55 | 0.50 | 0.54 | .59 | 0.08 |
| Weight (in kg) | 201 | 78.98 | 14.29 | 104 | 79.21 | 13.50 | 97 | 78.74 | 15.15 | 0.23 | .82 | 0.03 |
| Body Mass Index (kg/m2) | 201 | 25.78 | 3.63 | 104 | 25.81 | 3.59 | 97 | 25.74 | 3.68 | 0.14 | .89 | 0.02 |
| Gender (male = 0, female = 1) | 201 | 0.36 | 0.48 | 104 | 0.39 | 0.49 | 97 | 0.32 | 0.47 | 1.10 | .27 | 0.15 |
| Shift work (yes = 0, no = 1) | 191 | 0.57 | 0.50 | 96 | 0.53 | 0.50 | 95 | 0.60 | 0.49 | -0.96 | .34 | -0.14 |
| Smoking (no = 0, yes = 1) | 189 | 0.20 | 0.40 | 96 | 0.19 | 0.39 | 93 | 0.20 | 0.41 | -0.29 | .77 | -0.03 |
| Drinking days per week | 189 | 1.33 | 1.38 | 96 | 1.34 | 1.35 | 93 | 1.31 | 1.42 | 0.16 | .87 | 0.02 |
| Physical activity and CF | ||||||||||||
| Accelerometry (MVPA min/week) | 171 | 410.63 | 174.3 | 86 | 403.27 | 154.21 | 85 | 418.18 | 193.13 | -0.56 | .58 | -0.09 |
| CF (estimated VO2max in ml/kg/min) | 200 | 45.02 | 11.22 | 104 | 43.99 | 10.93 | 96 | 46.14 | 11.48 | -1.35 | .18 | -0.19 |
| Work stress | ||||||||||||
| JDC ratio | 190 | 0.96 | 0.19 | 97 | 0.94 | 0.19 | 93 | 0.98 | 0.20 | -1.21 | .23 | -0.21 |
| ERI ratio | 190 | 0.89 | 0.27 | 97 | 0.86 | 0.23 | 93 | 0.93 | 0.31 | -1.55 | .12 | -0.26 |
| Metabolic syndrome | ||||||||||||
| Waist circumference (cm) | 199 | 91.07 | 11.27 | 103 | 91.00 | 11.32 | 96 | 91.14 | 11.27 | -0.08 | .94 | -0.01 |
| TG (mmol·L–1) | 201 | 1.69 | 1.17 | 104 | 1.63 | 1.04 | 97 | 1.75 | 1.30 | -0.74 | .46 | -0.10 |
| HDL-C (mmol·L–1) | 200 | 1.82 | 0.40 | 104 | 1.80 | 0.41 | 96 | 1.84 | 0.40 | -0.65 | .52 | -1.00 |
| SBP (mm Hg) | 201 | 129.57 | 13.17 | 104 | 129.14 | 13.29 | 97 | 130.04 | 13.09 | -0.48 | .63 | -0.07 |
| DBP (mm Hg) | 201 | 85.10 | 10.25 | 104 | 84.96 | 10.07 | 97 | 85.26 | 10.49 | -0.21 | .84 | -0.03 |
| HbA1c (%) | 201 | 5.45 | 0.29 | 104 | 5.46 | 0.30 | 97 | 5.43 | 0.28 | 0.67 | .50 | 0.10 |
| Overall MetS score | 201 | 1.16 | 0.94 | 104 | 1.15 | 0.95 | 97 | 1.19 | 0.96 | -0.16 | .87 | -0.04 |
M = Mean; SD = Standard Deviation; d = Effektstärke Cohen’s d; Skew = Skewness; Kurt = Kurtosis; MetS (%) = Percentage of participants that met the specific criterion of Metabolic Syndrome; TG = Triglyceride; HDL-C = High-Density Lipoprotein Cholesterol; SBP = Systolic Blood Pressure; DBP = Diastolic Blood Pressure; HbA1c = Glycated Hemoglobin; MetS = Metabolic Syndrome; JDC = Job Demand and Control; ERI = Effort-Reward Imbalance; MVPA = Accelerometer-based Moderate to Vigorous Physical Activity; CF = Cardiorespiratory Fitness. Differences in N are due to different numbers of missing values for different variables. Sample size is lower for MVPA than CF because some participants had to be excluded from data analyses due to insufficient accelerometer wear-time.
Descriptive statistics for main study variables at baseline and follow-up for the participants who took part in the follow-up data assessment (N = 97).
| Baseline | |||||||
| Metabolic syndrome | Range | Skew | Kurt | MetS (%) | |||
| Waist circumference (cm) | 96 | 91.14 | 11.27 | 61.50–126.00 | 0.48 | 1.26 | 20 (20.6) |
| TG (mmol·L–1) | 97 | 1.75 | 1.30 | 0.51–7.35 | 2.52 | 7.10 | 34 (35.1) |
| HDL-C (mmol·L–1) | 96 | 1.84 | 0.40 | 0.93–2.59 | 0.02 | -0.54 | 2 (2.1) |
| SBP (mm Hg) | 97 | 130.04 | 13.09 | 107.00–172.0 | 0.59 | 0.44 | 59 (60.8) |
| DBP (mm Hg) | 97 | 85.26 | 10.49 | 63.50–118.0 | 0.21 | 0.04 | |
| HbA1c (%) | 97 | 5.43 | 0.28 | 4.90–6.80 | 1.65 | 6.36 | 1 (1.0) |
| Overall MetS score | 97 | 1.19 | 0.96 | 0.00–4.00 | 0.55 | 0.07 | |
| Work stress | |||||||
| JDC ratio | 93 | 0.98 | 0.20 | 0.54–1.50 | 0.60 | 0.25 | |
| ERI ratio | 93 | 0.93 | 0.31 | 0.33–2.02 | 0.79 | 1.01 | |
| Physical activity and CF | |||||||
| Accelerometry (MVPA min/week) | 85 | 418.18 | 193.13 | 49–1389 | 1.77 | 6.91 | |
| CF (estimated VO2max in ml/kg/min) | 96 | 46.14 | 11.48 | 24.20–89.40 | 0.69 | 1.09 | |
| Follow-up | |||||||
| Metabolic syndrome | Range | Skew | Kurt | MetS (%) | |||
| Waist circumference (cm) | 96 | 90.87 | 10.90 | 72.0–127.0 | 0.94 | 1.43 | 18 (18.6) |
| TG (mmol·L–1) | 97 | 1.84 | 0.98 | 0.7–7.4 | 2.69 | 11.05 | 47 (48.5) |
| HDL-C (mmol·L–1) | 96 | 1.73 | 0.56 | 0.9–5.5 | 3.34 | 20.64 | 5 (5.2) |
| SBP (mm Hg) | 97 | 127.46 | 13.49 | 103.0–172.0 | 0.71 | 0.73 | 47 (48.5) |
| DBP (mm Hg) | 97 | 82.41 | 10.03 | 62.5–112.5 | 0.61 | 0.45 | |
| HbA1c (%) | 96 | 5.23 | 0.92 | 4.8–6.8 | 0.95 | 0.82 | 2 (2.1) |
| Overall MetS score | 97 | 1.22 | 0.92 | 0–4 | 0.92 | -0.11 |
M = Mean; SD = Standard Deviation; Skew = Skewness; Kurt = Kurtosis; MetS (%) = Percentage of participants that met the specific criterion of Metabolic Syndrome; TG = Triglyceride; HDL-C = High-Density Lipoprotein Cholesterol; SBP = Systolic Blood Pressure; DBP = Diastolic Blood Pressure; HbA1c = Glycated Hemoglobin; MetS = Metabolic Syndrome; JDC = Job Demand and Control; ERI = Effort-Reward Imbalance; MVPA = Accelerometer-based Moderate to Vigorous Physical Activity; CF = Cardiorespiratory Fitness. Differences in N are due to different numbers of missing values for different variables. Sample size is lower for MVPA than CF because some participants had to be excluded from data analyses due to insufficient accelerometer wear-time.
Correlations between physical activity, cardiorespiratory fitness, work stress with cardiometabolic risk factors at baseline and follow-up, for the participants who took part in the follow-up data assessment.
| Baseline | MVPA | CF | JDC ratio | ERI ratio | Demand | Control | Effort | Reward |
| Waist circumference (cm) | -.21 | -.39 | .06 | .13 | .18 | .06 | .19 | -.02 |
| 84 | 95 | 92 | 92 | 92 | 92 | 92 | 92 | |
| TG (mmol·L–1) | -.04 | -.26 | -.02 | .07 | .16 | .15 | .09 | -.05 |
| 85 | 96 | 93 | 93 | 93 | 93 | 93 | 93 | |
| HDL-C (mmol·L–1) | .01 | .28 | -.16 | -.11 | -.13 | .09 | -.13 | .04 |
| 84 | 95 | 92 | 92 | 92 | 92 | 92 | 92 | |
| SBP (mm Hg) | -.21 | -.18 | -.05 | .20 | .11 | .12 | .25 | -.08 |
| 85 | 96 | 93 | 93 | 93 | 93 | 93 | 93 | |
| DBP (mm Hg) | -.21 | -.25 | -.05 | .19 | .12 | .15 | .24 | -.05 |
| 85 | 96 | 93 | 93 | 93 | 93 | 93 | 93 | |
| HbA1c (%) | -.27 | -.34 | -.12 | .05 | -.01 | .13 | .01 | -.05 |
| 85 | 95 | 93 | 93 | 93 | 93 | 93 | 93 | |
| Overall MetS score | -.14 | -.38 | -.05 | .10 | .12 | .16 | .17 | .02 |
| 85 | 96 | 93 | 93 | 93 | 93 | 93 | 93 | |
| Follow-up | MVPA | CF | JDC ratio | ERI ratio | Demand | Control | Effort | Reward |
| Waist circumference (cm) | -.17 | -.41 | .02 | .20 | .23 | .17 | .26* | -.06 |
| 84 | 95 | 92 | 92 | 92 | 92 | 92 | 92 | |
| TG (mmol·L–1) | -.15 | -.19 | .00 | .10 | .16 | .10 | .07 | -.11 |
| 85 | 96 | 93 | 93 | 93 | 93 | 93 | 93 | |
| HDL-C (mmol·L–1) | .08 | .27 | .02 | .07 | .14 | .08 | -.01 | -.13 |
| 85 | 96 | 93 | 93 | 93 | 93 | 93 | 93 | |
| SBP (mm Hg) | -.13 | -.19 | -.04 | .19 | .13 | .13 | .23 | -.08 |
| 85 | 96 | 93 | 93 | 93 | 93 | 93 | 93 | |
| DBP (mm Hg) | -.12 | -.25 | -.12 | .17 | .08 | .21 | .21 | -.08 |
| 85 | 96 | 93 | 93 | 93 | 93 | 93 | 93 | |
| HbA1c (%) | -.29 | -.26 | -.16 | .00 | -.08 | .08 | -.08 | -.09 |
| 84 | 95 | 92 | 92 | 92 | 92 | 92 | 92 | |
| Overall MetS score | -.21 | -.38 | -.10 | .10 | .08 | .19 | .12 | -.03 |
| 85 | 96 | 93 | 93 | 93 | 93 | 93 | 93 |
MVPA = Accelerometer-based Moderate-to-Vigorous Physical Activity; CF = Cardiorespiratory Fitness; JDC = Job Demand and Control; ERI = Effort-Reward Imbalance; TG = Triglyceride; HDL-C = High-Density Lipoprotein Cholesterol; SBP = Systolic Blood Pressure; DBP = Diastolic Blood Pressure; HbA1c = Glycated Hemoglobin; MetS = Metabolic Syndrome. Differences in N are due to different numbers of missing values for different variables. Sample size is lower for MVPA than CF because some participants had to be excluded from data analyses due to insufficient accelerometer wear-time.
* p < .05;
** p < .01.
Cross-sectional hierarchical linear regression with overall MetS score at baseline as dependent variable, for the participants who took part in the follow-up data assessment.
| Stress-buffering variable | ||||
|---|---|---|---|---|
| MVPA ( | CF (VO2max) ( | |||
| β | β | |||
| Step 1a | .10 | .10 | ||
| Age | .15 | .15 | ||
| Education | -.28 | -.22 | ||
| Step 2 | .01 | .01 | ||
| JDC ratio | -.11 | -.02 | ||
| ERI ratio | -.02 | .05 | ||
| Step 3 | .02 | .12 | ||
| Stress-buffering variable | -.17 | -.38 | ||
| Step 4 | .05 | .07 | ||
| JDC ratio x ERI ratio | .21 | .25 | ||
| Stress-buffer x JDC ratio | .07 | .04 | ||
| Stress-buffer x ERI ratio | -.19 | -.17 | ||
| Total | .18 | .30 | ||
MVPA = Accelerometer-based Moderate-to-Vigorous Physical Activity; CF = Cardiorespiratory Fitness; JDC = Job Demand and Control; ERI = Effort-Reward Imbalance. aOnly covariates were retained in the final model for which a significant bivariate association was found in the correlation analyses. Differences in N are due to different numbers of missing values for different variables. Sample size is lower for MVPA than CF because some participants had to be excluded from data analyses due to insufficient accelerometer wear-time.
* p < .05;
** p < .01.
Prospective hierarchical linear regression with overall MetS scores at follow-up as dependent variable, for the participants who took part in the follow-up data assessment.
| Stress-buffering variable | ||||
|---|---|---|---|---|
| MVPA ( | CF (VO2max) ( | |||
| β | β | |||
| Step 1a | .20 | .15 | ||
| Relationship status | -.33 | -.25 | ||
| Education | -.11 | -.11 | ||
| Step 2 | .12 | .14 | ||
| Overall MetS score at baseline | .37 | .33 | ||
| Step 3 | .01 | .01 | ||
| JDC ratio | -.05 | -.06 | ||
| ERI ratio | .00 | -.01 | ||
| Step 4 | .02 | .09 | ||
| Stress-buffering variable | -.18 | -.25 | ||
| Step 5 | .03 | .01 | ||
| JDC ratio x ERI ratio | -.17 | -.09 | ||
| Stress-buffer x JDC ratio | -.05 | .07 | ||
| Stress-buffer x ERI ratio | -.03 | -.05 | ||
| Total | .38 | .39 | ||
MetS = Metabolic Syndrome; MVPA = Accelerometer-based Moderate-to-Vigorous Physical Activity; CF = Cardiorespiratory Fitness; JDC = Job Demand and Control; ERI = Effort-Reward Imbalance. aOnly covariates were retained in the final model for which a significant bivariate association was found in the correlation analyses. Differences in N are due to different numbers of missing values for different variables. Sample size is lower for MVPA than CF because some participants had to be excluded from data analyses due to insufficient accelerometer wear-time.
* p < .05;
** p < .01.
Fig 1Graphical representation of the interaction between JDC ratio and ERI ratio in predicting overall MetS scores at baseline (n = 82).
Fig 2Scatterplot with line of best fit capturing the association between CF (VO2max) levels and overall MetS scores at follow-up (n = 96).
Fig 3A. Bar plot with confidence intervals (95%) regarding the distribution of overall MetS scores at baseline in the different fitness classifications following ASCM guidelines (n = 96). B. Bar plot with confidence intervals (95%) regarding the distribution of overall MetS scores at follow-up in the different fitness classifications following ASCM guidelines (n = 96).